These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 34403955)
1. Discovery of benzimidazole derivatives as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity. Ma Z; Jiang L; Li B; Liang D; Feng Y; Liu L; Jiang C Bioorg Med Chem; 2021 Sep; 46():116352. PubMed ID: 34403955 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis of 1,3-dimethylpyrimidine-2,4-diones as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity. Ma Z; Jiang L; Li G; Liang D; Li L; Liu L; Jiang C Bioorg Chem; 2020 Aug; 101():103971. PubMed ID: 32480173 [TBL] [Abstract][Full Text] [Related]
3. Discovery of coumarin-based selective aldehyde dehydrogenase 1A1 inhibitors with glucose metabolism improving activity. Liang D; Fan Y; Yang Z; Zhang Z; Liu M; Liu L; Jiang C Eur J Med Chem; 2020 Feb; 187():111923. PubMed ID: 31816557 [TBL] [Abstract][Full Text] [Related]
4. Discovery and development of selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors. Li B; Yang K; Liang D; Jiang C; Ma Z Eur J Med Chem; 2021 Jan; 209():112940. PubMed ID: 33328099 [TBL] [Abstract][Full Text] [Related]
5. Novel Disulfiram Derivatives as ALDH1a1-Selective Inhibitors. Omran Z Molecules; 2022 Jan; 27(2):. PubMed ID: 35056791 [TBL] [Abstract][Full Text] [Related]
6. Discovery of NCT-501, a Potent and Selective Theophylline-Based Inhibitor of Aldehyde Dehydrogenase 1A1 (ALDH1A1). Yang SM; Yasgar A; Miller B; Lal-Nag M; Brimacombe K; Hu X; Sun H; Wang A; Xu X; Nguyen K; Oppermann U; Ferrer M; Vasiliou V; Simeonov A; Jadhav A; Maloney DJ J Med Chem; 2015 Aug; 58(15):5967-78. PubMed ID: 26207746 [TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR and scaffold hopping based designing of benzo[d]ox-azol-2(3H)-one and 2-oxazolo[4,5-b]pyridin-2(3H)-one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: Synthesis and biological evaluation. Verma H; Narendra G; Raju B; Kumar M; Jain SK; Tung GK; Singh PK; Silakari O Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200108. PubMed ID: 35618489 [TBL] [Abstract][Full Text] [Related]
8. Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: Kinetic characterization and effect on human cancer cells. Jiménez R; Pequerul R; Amor A; Lorenzo J; Metwally K; Avilés FX; Parés X; Farrés J Chem Biol Interact; 2019 Jun; 306():123-130. PubMed ID: 30958995 [TBL] [Abstract][Full Text] [Related]
9. Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity. Yang SM; Martinez NJ; Yasgar A; Danchik C; Johansson C; Wang Y; Baljinnyam B; Wang AQ; Xu X; Shah P; Cheff D; Wang XS; Roth J; Lal-Nag M; Dunford JE; Oppermann U; Vasiliou V; Simeonov A; Jadhav A; Maloney DJ J Med Chem; 2018 Jun; 61(11):4883-4903. PubMed ID: 29767973 [TBL] [Abstract][Full Text] [Related]
10. Development of new disulfiram analogues as ALDH1a1-selective inhibitors. Omran Z Bioorg Med Chem Lett; 2021 May; 40():127958. PubMed ID: 33744437 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the Aldehyde Dehydrogenase 1/2 Family by Psoralen and Coumarin Derivatives. Buchman CD; Hurley TD J Med Chem; 2017 Mar; 60(6):2439-2455. PubMed ID: 28219011 [TBL] [Abstract][Full Text] [Related]
12. Investigation of an ALDH1A1-specific inhibitor for suppression of weight gain in a diet-induced mouse model of obesity. Haenisch M; Nguyen T; Fihn CA; Goldstein AS; Amory JK; Treuting P; Brabb T; Paik J Int J Obes (Lond); 2021 Jul; 45(7):1542-1552. PubMed ID: 33934107 [TBL] [Abstract][Full Text] [Related]
13. The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance. Moreb JS; Ucar D; Han S; Amory JK; Goldstein AS; Ostmark B; Chang LJ Chem Biol Interact; 2012 Jan; 195(1):52-60. PubMed ID: 22079344 [TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, Biological Evaluation and In Silico Study of Benzyloxybenzaldehyde Derivatives as Selective ALDH1A3 Inhibitors. Ibrahim AIM; Ikhmais B; Batlle E; AbuHarb WK; Jha V; Jaradat KT; Jiménez R; Pequerul R; Parés X; Farrés J; Pors K Molecules; 2021 Sep; 26(19):. PubMed ID: 34641313 [TBL] [Abstract][Full Text] [Related]
15. Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors. Morgan CA; Hurley TD J Med Chem; 2015 Feb; 58(4):1964-75. PubMed ID: 25634381 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and β-glucuronidase inhibitory potential of benzimidazole derivatives. Khan KM; Khan M; Ambreen N; Rahim F; Naureen S; Perveen S; Choudhary MI; Voelter W Med Chem; 2012 May; 8(3):421-7. PubMed ID: 22530898 [TBL] [Abstract][Full Text] [Related]
17. Discovery of a series of aromatic lactones as ALDH1/2-directed inhibitors. Buchman CD; Mahalingan KK; Hurley TD Chem Biol Interact; 2015 Jun; 234():38-44. PubMed ID: 25641190 [TBL] [Abstract][Full Text] [Related]
18. Discovery of a benzimidazole series as the first highly potent and selective ACSL1 inhibitors. Hayashi K; Kondo N; Omori N; Yoshimoto R; Hato M; Shigaki S; Nagasawa A; Ito M; Okuno T Bioorg Med Chem Lett; 2021 Feb; 33():127722. PubMed ID: 33285268 [TBL] [Abstract][Full Text] [Related]
19. Development of selective inhibitors for human aldehyde dehydrogenase 3A1 (ALDH3A1) for the enhancement of cyclophosphamide cytotoxicity. Parajuli B; Georgiadis TM; Fishel ML; Hurley TD Chembiochem; 2014 Mar; 15(5):701-12. PubMed ID: 24677340 [TBL] [Abstract][Full Text] [Related]
20. Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer. Rebollido-Rios R; Venton G; Sánchez-Redondo S; Iglesias I Felip C; Fournet G; González E; Romero Fernández W; Borroto Escuela DO; Di Stefano B; Penarroche-Díaz R; Martin G; Ceylan I; Costello R; Perez-Alea M Oncogene; 2020 Mar; 39(13):2756-2771. PubMed ID: 32015486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]